PharmD Degree Program

Medical and pharmacy students jointly tackle health care’s most pressing dilemmas

Fri Feb 22, 2019
Student in discussion with Rodriguez-Monguio
Levi Gadye

Pharmacy student Shafat Selim (right) discusses the complexities of the orphan drug market with School of Pharmacy faculty member Rosa Rodriguez-Monguio, PhD, (left) during a mini-course session.

A two-week course brought first-year UCSF medical and pharmacy students together, for the first time, to grapple with controversies and challenges in health care using scientific evidence and faculty-led discussion.

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

Tue Feb 12, 2019
Goyan
UC Regents

Jere E. Goyan, PhD, was the longest-serving dean of the School of Pharmacy and commissioner of the FDA.

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

Creating an inexhaustible database for drug molecules

Mon Feb 11, 2019
Shoichet in his office
Elisabeth Fall

Brian Shoichet, PhD, brought his drug discovery software to an enormous database of small molecules.

School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.

QBI fellowship fosters curiosity and perseverance for women scientists

Mon Jan 28, 2019
Kyosiimire-Lugemwa
QBI

Jacqueline Kyosiimire-Lugemwa, PhD, was the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences.

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about...

CRISPR-based obesity treatment shows promise for other diseases

Thu Jan 17, 2019
Ahituv, right, works in his lab with postdoc Fumitaka Inoue
Susan Merrell

Nadav Ahituv, PhD, right, was able to curb obesity in mice by tweaking two genes involved in controlling appetite.

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

Fraser appointed to Bowes Biomedical Investigator Program

Wed Jan 9, 2019
Fraser stands in front of a whiteboard
Elisabeth Fall

James Fraser, PhD, developed new ways of doing crystallography over a wide range of temperatures.

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Tue Jan 8, 2019
Keiser
UCSF

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will support his research into novel therapies for neuro­de­gener­a­tion.

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Combination drug therapy overcomes drug-resistant lung cancer in the lab

Wed Dec 19, 2018
Chest x-ray, showing a possible lung cancer tumor.
National Cancer Institute

A chest x-ray showing a possible lung cancer tumor (National Cancer Institute)

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

Ortiz de Montellano elected fellow of the Royal Society of Chemistry

Mon Dec 17, 2018
Ortiz de Montellano
© majedphoto.com

Paul Ortiz de Montellano, PhD, is an expert on P450 enzymes and his latest work looks at their role in tuberculosis infections.

Ortiz de Montellano gained renown for his work with cytochrome P450 enzymes, which help the liver metabolize drugs and other chemicals, and regulate hormone levels.

QBI scientists decipher how Ebola, dengue, and Zika infect human cells

Fri Dec 14, 2018
Krogan
Chris Goodfellow (Gladstone Institutes)

Nevan Krogan, PhD, senior author on the two studies and director of QBI

In a pair of recent studies, scientists at the Quantitative Biosciences Institute uncovered how Ebola, dengue, and Zika hijack human proteins to infect human cells, findings that point to new approaches for treating these diseases.

Pages